Cediranib (AZD2171, RECENTIN™) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal Cancer
A phase 3 trial of Cediranib, FOLFOX, Leucovorin, Oxaliplatin, Fluorouracil and CAPOX in Colorectal cancer, run by AstraZeneca, completed.
Overview
Cediranib (AZD2171, RECENTIN™) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal Cancer is a phase 3 interventional study registered as NCT00399035 by AstraZeneca, with 1254 participants recorded, started 2006-11 and reaching its primary completion in 2010-03. Interventions recorded: Cediranib, FOLFOX (5-fluorouracil, Leucovorin, Oxaliplatin), XELOX (Capecitabine and Oxaliplatin), Cediranib Placebo. Conditions recorded: Metastatic Colorectal Cancer.
Linked to the drug Cediranib because the registry names it among its interventions and Colorectal cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialFUDR/Oxaliplatin HAI Plus Irinotecan vs. FOLFOXIRI Chemotherapy in Treating Initially Unresectable CRCLM
Shares Leucovorin (folinic acid), Oxaliplatin, Fluorouracil (5-FU), Colorectal cancer and the tag pipeline.
- TrialPalliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer
Shares Leucovorin (folinic acid), Fluorouracil (5-FU), Colorectal cancer and the tag pipeline.
- TrialTesting Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
Shares Leucovorin (folinic acid), Oxaliplatin, Fluorouracil (5-FU), Colorectal cancer and the tag pipeline.
- TrialCombination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
Shares Leucovorin (folinic acid), Fluorouracil (5-FU), Colorectal cancer and the tag pipeline.
- TrialG-CSF in Preventing Neutropenia During First-Line Treatment With Chemotherapy and Bevacizumab in Patients With Metastatic Colorectal Cancer
Shares Leucovorin (folinic acid), Fluorouracil (5-FU), Colorectal cancer and the tag pipeline.
- TrialEvaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard Therapy in Patients With Gastrointestinal Cancer
Shares Leucovorin (folinic acid), Oxaliplatin and the tag pipeline.
- TrialA Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Shares Leucovorin (folinic acid), Oxaliplatin, Colorectal cancer and the tag pipeline.
- TrialAn RCT of Concurrent and Maintenance Cediranib in Women With Platinum-sensitive Relapsed Ovarian Cancer
Shares Cediranib and the tag pipeline.